Nanostructured Glycopolymer Augmented Liposomes to Elucidate Carbohydrate-Mediated Targeting
Abstract
Carbohydrate receptors on alveolar macrophages are attractive targets for receptor-mediated delivery of nanostructured therapeutics. In this study, we employed reversible addition fragmentation chain transfer polymerization to synthesize neoglycopolymers, consisting of mannose- and galactose methacrylate-based monomers copolymerized with cholesterol methacrylate for use in functional liposome studies. Glycopolymer-functional liposomes were employed to elucidate macrophage mannose receptor (CD206) and macrophage galactose-type lectin (CD301) targeting in both primary macrophage and immortal macrophage cell lines. Expression of CD206 and CD301 was observed to vary significantly between cell lines (murine alveolar macrophage, murine bone marrow-derived macrophage, RAW264.7, and MH-S), which has significant implications in in vitro targeting and uptake studies. Synthetic glycopolymers and glycopolymer augmented liposomes demonstrated specific receptor-mediated uptake in a manner dependent on carbohydrate receptor expression. These results establish a platform capable of probing endogenous carbohydrate receptor-mediated targeting via glycofunctional nanomaterials.
Recommended Citation
J. Chen et al., "Nanostructured Glycopolymer Augmented Liposomes to Elucidate Carbohydrate-Mediated Targeting," Nanomedicine: Nanotechnology, Biology and Medicine, vol. 12, no. 7, pp. 2031 - 2041, Elsevier Inc., Oct 2016.
The definitive version is available at https://doi.org/10.1016/j.nano.2016.05.001
Department(s)
Materials Science and Engineering
Keywords and Phrases
Carbohydrate; Glycopolymer; Liposome; Macrophage
International Standard Serial Number (ISSN)
1549-9634
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2016 Elsevier Inc., All rights reserved.
Publication Date
01 Oct 2016
PubMed ID
27184097